Labopharm Inc.

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Study to Compare the Relative Bioavailability of Two 200 Mg Tramadol Hydrochloride Tablet Products Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Tramadol HCl

First Posted Date: 2009-02-03

Last Posted Date: 2012-04-30

Lead Sponsor: Labopharm Inc.

Target Recruit Count: 26

Registration Number: NCT00834366

Study of Two Tramadol Contramid® OAD 300 mg Controlled-Release Tablets From Two Different Manufacturing Sites Following a 300 mg Dose in Healthy Subjects Under Fasting and Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Tramadol hydrochloride
Drug: Tramadol HCl

First Posted Date: 2009-02-03

Last Posted Date: 2012-04-30

Lead Sponsor: Labopharm Inc.

Target Recruit Count: 36

Registration Number: NCT00834912

A Dose Linearity Study of the Labopharm Formulation of Tramadol HCl/Contramid®, 100 mg, 200 mg and 300 mg After A Single Oral Administration In Fasting Condition, In Healthy Human Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Tramadol HCl

First Posted Date: 2009-02-03

Last Posted Date: 2012-04-27

Lead Sponsor: Labopharm Inc.

Target Recruit Count: 27

Registration Number: NCT00834808

A Study to Compare the Bioavailability of Two Tramadol Hydrochloride Tablet Products (50 mg and 200 mg, Respectively) at Steady-state Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy Subjects
Pharmacokinetics
Bioavailability

Interventions: Drug: Tramadol HCl

First Posted Date: 2009-02-03

Last Posted Date: 2012-04-27

Lead Sponsor: Labopharm Inc.

Target Recruit Count: 26

Registration Number: NCT00834288

A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol HCl Once-a-Day Versus Placebo for the Treatment of Pain Due to Osteoarthritis

Phase 3

Completed

Conditions: Pain
Osteoarthritis

Interventions: Drug: Placebo
Drug: Tramadol Once a day

First Posted Date: 2009-02-02

Last Posted Date: 2012-04-30

Lead Sponsor: Labopharm Inc.

Target Recruit Count: 1028

Registration Number: NCT00833794

An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee

Phase 3

Completed

Conditions: Osteoarthritis, Knee

Interventions: Drug: Tramadol Once A Day

First Posted Date: 2009-02-02

Last Posted Date: 2012-04-30

Lead Sponsor: Labopharm Inc.

Target Recruit Count: 392

Registration Number: NCT00833911

A Four-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol Once a Day 100, 200 and 300 mg Versus Placebo for the Treatment of Pain Due to Osteoarthritis of the Knee

Phase 3

Completed

Conditions: Pain
Osteoarthritis, Knee

Interventions: Drug: Tramadol Once A Day
Drug: Placebo

First Posted Date: 2009-01-30

Last Posted Date: 2012-04-30

Lead Sponsor: Labopharm Inc.

Target Recruit Count: 565

Registration Number: NCT00832416

A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.

Phase 3

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: Trazodone Hydrochloride (HCl) Extended-Release Tablets
Drug: Placebo

First Posted Date: 2008-10-20

Last Posted Date: 2012-04-27

Lead Sponsor: Labopharm Inc.

Target Recruit Count: 412

Registration Number: NCT00775203

A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Acetaminophen and Tramadol Combination BID Versus Placebo for the Treatment of Acute Low Back Pain

Phase 3

Completed

Conditions: Acute Low Back Pain

Interventions: Drug: Combination drug (Acetaminophen + Tramadol)
Drug: Placebo

First Posted Date: 2008-03-26

Last Posted Date: 2012-05-01

Lead Sponsor: Labopharm Inc.

Target Recruit Count: 277

Registration Number: NCT00643383

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy